INOVIO PHARMACEUTICALS INC (INO) Stock Cash Flow
NASDAQ:INO - Nasdaq - US45773H4092 - Common Stock
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -112.88M | -135.12M | -279.82M | -303.66M | -167.47M | |||
| Depreciation Amortization | 1.91M | 2.77M | 4.15M | 3.56M | 3.59M | |||
| Income Taxes - Deferred | N/A | -32.10K | N/A | 0.00 | 0.00 | |||
| Change In Working Capital | -4.05M | -10.26M | 19.83M | 50.35M | -71.07M | |||
| Interest Paid | 533.49K | 1.07M | 1.07M | 1.08M | 4.62M | |||
| Other non cash items | 4.36M | 18.28M | 39.62M | 34.04M | 56.98M | |||
| OPERATING CASH FLOW | -110.69M | -124.37M | -216.22M | -215.71M | -177.98M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -487.83K | -320.90K | -969.20K | -1.23M | -1.52M | |||
| Other Investing Activity | 89.86M | 87.68M | 110.56M | -174.11M | -57.28M | |||
| INVESTING CASH FLOW | 89.37M | 87.36M | 109.59M | -175.34M | -58.80M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | 0.00 | 0.00 | 171.60K | |||
| Stock Issued/Repurchased | 40.58M | 5.00M | 81.84M | 211.50M | 462.73M | |||
| Other Financing Activity | N/A | N/A | 0.00 | 0.00 | 2.38M | |||
| FINANCING CASH FLOW | 24.17M | 5.00M | 81.84M | 211.50M | 465.28M | |||
| Exchange Rate Effect | 32.90K | -3.90K | -25.60K | -30.10K | 27.20K | |||
| CHANGE IN CASH | 2.88M | -32.02M | -24.81M | -179.58M | 228.53M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -110.69M | -124.37M | -216.22M | -215.71M | -177.98M | |||
| Capital Expenditure | -487.83K | -320.90K | -969.20K | -1.23M | -1.52M | |||
| FREE CASH FLOW | -111.18M | -124.69M | -217.18M | -216.94M | -179.50M | |||
All data in USD